Related references
Note: Only part of the references are listed.Clinical Trials of Broadly Neutralizing Monoclonal Antibodies for Human Immunodeficiency Virus Prevention: A Review
Sharana Mahomed et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
Long-acting injectable HIV therapies: the next frontier
John Thornhill et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2021)
Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trial
Kathryn E. Stephenson et al.
NATURE MEDICINE (2021)
A Phase 2b Study to Evaluate the Safety and Efficacy of VRC01 Broadly Neutralizing Monoclonal Antibody in Reducing Acquisition of HIV-1 Infection in Women in Sub-Saharan Africa: Baseline Findings
Nyaradzo M. Mgodi et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2021)
FDA approves 100th monoclonal antibody product
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2021)
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition
L. Corey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Broadly neutralizing antibodies for HIV-1 prevention and therapy
Boris Julg et al.
SEMINARS IN IMMUNOLOGY (2021)
Broadly Neutralizing Antibodies for HIV-1 Prevention
Stephen R. Walsh et al.
FRONTIERS IN IMMUNOLOGY (2021)
Framework Mutations of the 10-1074 bnAb Increase Conformational Stability, Manufacturability, and Stability While Preserving Full Neutralization Activity
Bruce A. Kerwin et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Broadly Neutralizing Antibodies for HIV Prevention
Shelly T. Karuna et al.
ANNUAL REVIEW OF MEDICINE, VOL 71, 2020 (2020)
A Bispecific Antibody That Simultaneously Recognizes the V2-and V3-Glycan Epitopes of the HIV-1 Envelope Glycoprotein Is Broader and More Potent than Its Parental Antibodies
Meredith E. Davis-Gardner et al.
MBIO (2020)
Fc-mediated effector function contributes to the in vivo antiviral effect of an HIV neutralizing antibody
Mangaiarkarasi Asokan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Quantifying the contribution of Fc-mediated effector functions to the antiviral activity of anti-HIV-1 IgG1 antibodies in vivo
Pengfei Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Adeno-Associated Virus Delivery of Anti-HIV Monoclonal Antibodies Can Drive Long-Term Virologic Suppression
Jose M. Martinez-Navio et al.
IMMUNITY (2019)
The Miami Monkey: A Sunny Alternative to the Berlin Patient
Rachel A. Liberatore et al.
IMMUNITY (2019)
Improvement of antibody functionality by structure-guided paratope engraftment
Qingbo Liu et al.
NATURE COMMUNICATIONS (2019)
A Structure-Based Drug Discovery Paradigm
Maria Batool et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The potential of engineered antibodies for HIV-1 therapy and cure
Marloes Grobben et al.
CURRENT OPINION IN VIROLOGY (2019)
Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trial
Martin R. Gaudinski et al.
LANCET HIV (2019)
Tutorial on Monoclonal Antibody Pharmacokinetics and Its Considerations in Early Development
Meric Ovacik et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2018)
New-Generation High-Potency and Designer Antibodies: Role in HIV-1 Treatment
Lucio Gama et al.
ANNUAL REVIEW OF MEDICINE, VOL 69 (2018)
Surface-Matrix Screening Identifies Semi-specific Interactions that Improve Potency of a Near Pan-reactive HIV-1-Neutralizing Antibody
Young D. Kwon et al.
CELL REPORTS (2018)
Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults
Martin R. Gaudinski et al.
PLOS MEDICINE (2018)
Relationship between latent and rebound viruses in a clinical trial of anti-HIV-1 antibody 3BNC117
Yehuda Z. Cohen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Combination therapy with anti-HIV-1 antibodies maintains viral suppression
Pilar Mendoza et al.
NATURE (2018)
Engineering multi-specific antibodies against HIV-1
Neal N. Padte et al.
RETROVIROLOGY (2018)
Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study
Andrew E. Grulich et al.
LANCET HIV (2018)
Life expectancy of HIV-positive people after starting combination antiretroviral therapy: a meta-analysis
S. Teeraananchai et al.
HIV MEDICINE (2017)
Antibody 10-1074 suppresses viremia in HIV-1-infected individuals
Marina Caskey et al.
NATURE MEDICINE (2017)
Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques
Ling Xu et al.
SCIENCE (2017)
Engineered Bispecific Antibodies with Exquisite HIV-1-Neutralizing Activity
Yaoxing Huang et al.
CELL (2016)
HIV Broadly Neutralizing Antibodies: Taking Good Care Of The 98%
Devin Sok et al.
IMMUNITY (2016)
Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption
K. J. Bar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Clade C
Kshitij Wagh et al.
PLOS PATHOGENS (2016)
Broadly Neutralizing Antibodies for HIV Eradication
Kathryn E. Stephenson et al.
CURRENT HIV/AIDS REPORTS (2016)
Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults
J. E. Ledgerwood et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2015)
Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection
Rebecca M. Lynch et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Enhanced Potency of a Broadly Neutralizing HIV-1 Antibody In Vitro Improves Protection against Lentiviral Infection In Vivo
Rebecca S. Rudicell et al.
JOURNAL OF VIROLOGY (2014)
Enhanced neonatal Fc receptor function improves protection against primate SHIV infection
Sung-Youl Ko et al.
NATURE (2014)
The Antibody Response against HIV-1
Julie Overbaugh et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding
Johannes F. Scheid et al.
SCIENCE (2011)
Origins of HIV and the AIDS Pandemic
Paul M. Sharp et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2011)
Enhanced antibody half-life improves in vivo activity
Jonathan Zalevsky et al.
NATURE BIOTECHNOLOGY (2010)
Therapeutic antibodies: successes, limitations and hopes for the future
Patrick Chames et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Share Paper
